PCOS weight loss: myo-inositol vs metformin – which works better?
NCT ID NCT07387679
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared myo-inositol and metformin for helping women with polycystic ovary syndrome (PCOS) lose weight. Sixty women took either myo-inositol or metformin for three months. The main goal was to see which drug reduced body mass index (BMI) more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- myo-inositol and metformin
- What this could lead to
- If myo-inositol works as well as metformin, it could offer a gentler option for managing weight in PCOS.
- What could go wrong
- This is a small, completed trial with only 60 participants. Results may not apply to everyone, and neither drug is a cure—weight management may need ongoing treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bahwal Victoria Hospital
Bahawalpur, Punjab Province, 63100, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can stretching or massage ease PCOS period pain? new study investigates
- Could diabetes meds help women with PCOS get pregnant?
- New drug combo may help women with PCOS ovulate when standard treatment fails
- Could a diabetes drug boost fertility in PCOS? new trial tests combo therapy
- Which hormone protocol yields healthier embryos for PCOS patients?
- Could pollution and sleep habits be messing with your hormones? new study investigates.